Business Context and Reporting Period
Company: Albemarle Corporation
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2009
Business Overview: Albemarle is a global developer, manufacturer, and marketer of highly-engineered specialty chemicals, operating through three segments: Polymer Additives, Catalysts, and Fine Chemicals. The company serves diverse industries including petroleum refining, consumer electronics, automotive, and pharmaceuticals.
Key Financial Metrics
| Metric (in millions) | Q3 2009 | Q3 2008 | 9M 2009 | 9M 2008 |
|---|---|---|---|---|
| Net Sales | $515.3 | $660.5 | $1,447.2 | $1,949.4 |
| Gross Profit | $134.1 | $154.2 | $334.4 | $484.6 |
| Gross Margin | 26.0% | 23.3% | 23.1% | 24.9% |
| Operating Profit | $62.9 | $76.9 | $122.8 | $238.5 |
| Net Income (Albemarle) | $52.1 | $56.2 | $116.0 | $181.1 |
| Diluted EPS | $0.57 | $0.61 | $1.26 | $1.95 |
| Cash from Operations (9M) | $259.4 million (vs. $161.8 million in 9M 2008) | |||
| Cash & Equivalents (Sep 30, 2009) | $260.4 million | |||
| Total Debt (Sep 30, 2009) | $820.8 million ($27.7M current; $793.1M long-term) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 22% in Q3 and 26% in the nine-month period compared to 2008. This was driven primarily by volume declines across all segments due to softness in consumer electronics, automotive, and construction sectors.
- Profitability: Despite lower sales, Q3 gross margin improved to 26.0% from 23.3% in 2008 due to cost reduction initiatives. However, nine-month operating profit dropped 49% to $122.8 million, impacted by volume declines and a $12.4 million charge related to the Port de Bouc facility divestiture settlement.
- Segment Performance:
- Polymer Additives: Sales down 25% (Q3) and 36% (9M); segment income down 5% (Q3) and 65% (9M).
- Catalysts: Sales down 18% (Q3) and 16% (9M); segment income down 8% (Q3) and 19% (9M).
- Fine Chemicals: Sales down 22% (Q3) and 24% (9M); segment income down 43% (Q3) and 60% (9M).
- Cost Management: SG&A expenses decreased 6% in Q3 and 20% in the nine-month period due to reduced discretionary spending and personnel costs. R&D expenses also declined.
- Tax Rate: The effective tax rate for the nine months ended September 30, 2009, was negative (1.6%) due to non-recurring tax benefits totaling $15.7 million, including settlements with the IRS and benefits related to the Port de Bouc divestiture.
Guidance, Outlook, and Risks
- Outlook: Management observes signs of a slow, steady end-market recovery with positive order trends. They anticipate continued performance improvement in the second half of 2009 driven by cost reduction and productivity initiatives. A stronger balance sheet is expected at year-end.
- Capital Expenditures: Expected to be approximately $95 to $100 million for 2009, primarily for plant and equipment improvements in Catalysts and Fine Chemicals.
- Dividends: Quarterly dividend increased by 4% to $0.125 per share in 2009.
- Restructuring: Consultations initiated in late September 2009 regarding potential restructuring at EU headquarters and plants in Germany and the Netherlands. Estimated charges could range from $10 million to $15 million in future quarters.
- Liquidity: The company maintains a $675 million revolving credit facility with $280 million available at September 30, 2009. Management believes cash flow and available credit are sufficient to fund operations, debt service, and capital expenditures.
- Risks: Key risks include deterioration in economic conditions, raw material cost volatility (specifically metals and natural gas), foreign currency fluctuations, and potential environmental liabilities (including an ongoing EPA notice of violation in South Carolina).
Investor Verification Checklist
- Volume Recovery: Verify the pace of demand recovery in the consumer electronics, automotive, and construction sectors to assess sales trajectory.
- Port de Bouc Settlement: Confirm that the $12.4 million charge is fully settled and no further cash payments are required beyond 2009.
- Upcoming Restructuring Costs: Monitor the outcome of EU consultations for potential $10-$15 million charges in future quarters.
- Tax Rate Normalization: Assess the sustainability of the effective tax rate, noting the 2009 rate was skewed by one-time non-recurring benefits; management expects a ~12% rate excluding these items.
- Debt Covenants: Review compliance with the March 2007 credit agreement covenants, specifically the debt-to-EBITDA ratio, given the significant drop in earnings.
- Environmental Liabilities: Track the status of the EPA Notice of Violation in Orangeburg, SC, and potential future remediation costs estimated up to $18 million.